Comments
India's Piramal buys Bayer's potential Alzheimer drug
16.04.2012. | (Reuters) - Indian drugmaker Piramal Healthcare has agreed to buy a research and development portfolio from Bayer AG, the company said, in a deal that gives Piramal rights to florbetaben, a possible Alzheimer treatment....
